LifeArc
Overview
LifeArc is a self-funded medical research charity and investment firm that translates early-stage science into healthcare treatments and diagnostics, with a venture arm that invests in therapeutics and medtech companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Exciva GmbH | Jan 2026 | Series B | Co-investor |
| PhalconBio GmbH | Feb 2025 | Grant | Co-investor |
| Glox Therapeutics | Jan 2025 | Grant | Co-investor |
| Pathway Bio | Jan 2025 | Accelerator | Co-investor |
| Centauri Therapeutics Limited | Nov 2024 | Grant | Co-investor |
Key People
Catherine Briggs
Reward and Benefits Partner
Andrew Gerard Cairns
Principal Scientist
Beth Wensley
Principal Scientist - Protein Sciences
Carolyn Clarke
Principal Scientist
Chris Coward
Principal Research Scientist
Colin Robinson
Principal Scientist
David McCoull
Principal Scientist
David P.
Principal Scientist
Debra Taylor
Senior Principal Scientist, Drug Discovery Manager
Ed M.
Principal Machine Learning Scientist
Kristian Birchall
Principal Scientist
Martina Trokter
Principal Scientist
Natasha Ratcliffe
Principal, Patient Engagement
Paul Smith
Principal Scientist
Rachel Forfar
Principal Scientist
Rodrigo Abreu
Principal Scientist
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
